Fengqi Zhou

Kunming University of Science and Technology — China

Engineering · Physical Sciences

29h-index3.1kcitations232works5.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Plasmonic and Surface Plasmon Research(33), Metamaterials and Metasurfaces Applications(25), Adaptive Control of Nonlinear Systems(21), Guidance and Control Systems(21), Photonic and Optical Devices(18)

Publications232 total

Inhibition of ADORA3 Accelerates Hematoma Resolution and Neurological Recovery after ICH
Cerebrovascular Diseases·2025
Theranostic nanoplatform for triple-negative breast cancer therapy: Autophagy suppression-coordinated siRNA delivery triggers apoptosis, ferroptosis, and pyroptosis via photothermal activation
Chemical Engineering Journal·2025· 1 cited
Thermodynamic assessment of CaO-Al2O3-SiO2-Ce2O3 subsystems
Calphad·2025· 1 cited
The Effect of Cerium on the Modification Behavior of Sulfides in Free-Cutting Steel
Metallurgical and Materials Transactions B·2025
Supplementary Figure S1 from UBE2T-Mediated HP1α Ubiquitination Enhances Nucleolar Function and Promotes the Progression of IDH1/TP53-Mutant Glioma
2025Open Access
Supplementary Figure S6 from UBE2T-Mediated HP1α Ubiquitination Enhances Nucleolar Function and Promotes the Progression of IDH1/TP53-Mutant Glioma
2025Open Access
Supplementary Table S2 from UBE2T-Mediated HP1α Ubiquitination Enhances Nucleolar Function and Promotes the Progression of IDH1/TP53-Mutant Glioma
2025Open Access
Supplementary Figure S7 from UBE2T-Mediated HP1α Ubiquitination Enhances Nucleolar Function and Promotes the Progression of IDH1/TP53-Mutant Glioma
2025Open Access
Supplementary Figure S5 from UBE2T-Mediated HP1α Ubiquitination Enhances Nucleolar Function and Promotes the Progression of IDH1/TP53-Mutant Glioma
2025Open Access
Data from UBE2T-Mediated HP1α Ubiquitination Enhances Nucleolar Function and Promotes the Progression of IDH1/TP53-Mutant Glioma
2025Open Access
Supplementary Figure S4 from UBE2T-Mediated HP1α Ubiquitination Enhances Nucleolar Function and Promotes the Progression of IDH1/TP53-Mutant Glioma
2025Open Access
Supplementary Table S3 from UBE2T-Mediated HP1α Ubiquitination Enhances Nucleolar Function and Promotes the Progression of IDH1/TP53-Mutant Glioma
2025Open Access
Supplementary Figure S2 from UBE2T-Mediated HP1α Ubiquitination Enhances Nucleolar Function and Promotes the Progression of IDH1/TP53-Mutant Glioma
2025Open Access
Supplementary Table S1 from UBE2T-Mediated HP1α Ubiquitination Enhances Nucleolar Function and Promotes the Progression of IDH1/TP53-Mutant Glioma
2025Open Access
Supplementary Figure S3 from UBE2T-Mediated HP1α Ubiquitination Enhances Nucleolar Function and Promotes the Progression of IDH1/TP53-Mutant Glioma
2025Open Access
HOF-on-MOF heterostructured enzyme mimic with high catalytic activity for colorimetric detection of β-bungarotoxin
Sensors and Actuators B Chemical·2025· 1 cited
Twice‐daily administration improves the effectiveness of 0.01% atropine for controlling myopia in slowing axial elongation and refractive progression
Ophthalmic and Physiological Optics·2025· 1 cited
UBE2T-Mediated HP1α Ubiquitination Enhances Nucleolar Function and Promotes the Progression of IDH1/TP53-Mutant Glioma
Clinical Cancer Research·2025· 1 citedOpen Access
Effect of Cu on CGHAZ Low-Temperature Impact Toughness in Ca-Ti-Deoxidized HSLA Steels After HHIW: Insights from Inclusions, Microstructures, and Fracture Analysis
Metallurgical and Materials Transactions B·2025· 2 cited
Blood-brain barrier alterations as an initiator of brain metastasis from lung cancer: a new take on an old story
Cancer Gene Therapy·2025· 3 cited
page 1 of 12Next →

Frequent Co-authors

Zhimin Liu(25), Xin Luo(23), Xiao Zhang(16), Zhenbin Zhang(15), Enduo Gao(14), Hongjian Li(10), Tianfu Yu(8), Yingyi Wang(7), Yipeng Qin(7), Shanshan Zhuo(7), Hui Xu(6), Zao Yi(5), Yongping You(5), Junxia Zhang(5), Jing Gao(4), Haijun Yu(4), Xiupeng Xu(4), Ning Liu(4), Jiawei Wang(4), Yuqing Wang(4)